Integrating Hypoxia Signatures from scRNA-seq and Bulk Transcriptomes for Prognosis Prediction and Precision Therapy in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study identifies hypoxia-related genes in cervical cancer (CESC) and develops a risk score (CSHRS) model. This model aids in predicting prognosis and guiding personalized treatment strategies for CESC patients.
Area Of Science
- Oncology
- Genomics
- Biostatistics
Background
- Hypoxia is prevalent in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), contributing to tumor heterogeneity.
- Understanding hypoxia mechanisms is crucial for developing personalized CESC therapies.
Purpose Of The Study
- To identify CESC-specific hypoxia-related genes.
- To construct a prognostic risk model (CSHRS) for CESC.
- To integrate clinicopathological features for precision treatment strategies.
Main Methods
- Weighted Gene Correlation Network Analysis (WGCNA) and FindMarkers for gene identification.
- Least Absolute Shrinkage and Selection Operator (LASSO) and Cox regression for risk model construction.
- Analysis of immune infiltration, mutations, and drug resistance in relation to the risk model.
Main Results
- Identified CESC-specific hypoxia gene sets.
- Developed a CSHRS risk model classifying patients into distinct prognostic groups.
- Demonstrated the model's ability to evaluate tumor microenvironment and predict outcomes.
Conclusions
- The CSHRS risk model provides comprehensive insights into CESC tumor microenvironment.
- This model offers accurate prognostic predictions and supports personalized treatment decisions for CESC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.